Drugs / 11C-EMO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05105542 | Apr 2021 → Oct 2023 | schizoaffective disorder, schizophrenia | Yale University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | \[11C\]EMO | “The radiotracer, \[11C\]EMO, will be administered at the beginning of each PET scan.” NCT05105542 ↗ |
| Modality | Diagnostic / imaging agent | “A Novel PET Radiotracer” NCT05105542 ↗ |